Improving Maternal and Neonatal Care-seeking Through a Video-informed Training Session During the Third Trimester of Pregnancy (Taabo T3)
14 de septiembre de 2026 actualizado por: Swiss Tropical & Public Health Institute
Improving Maternal and Neonatal Care-Seeking Through a Video-Informed Training Session During the Third Trimester of Pregnancy
This study is a randomized controlled trial evaluating the impact of a video-informed training session on maternal and newborn health care seeking in rural Côte d'Ivoire.
Descripción general del estudio
Estado
Aún no reclutando
Condiciones
Intervención / Tratamiento
Descripción detallada
In Taabo, Côte d'Ivoire, many women do not receive recommended care during the third trimester of pregnancy or the early postpartum period, contributing to adverse maternal and neonatal health outcomes.
In this individual-level open-label randomized controlled trial, we will evaluate the impact of an information and planning intervention on timely care-seeking during the third trimester of pregnancy and the early postpartum period.
The study will enroll 800 women who are currently in the third trimester of pregnancy and randomize them to one of two groups: (1) control, or (2) information video and planning session for the pregnant women and her partner.
A baseline survey will be performed at the time of enrollment, and outcomes will be evaluated using an endline survey 6-8 weeks after the end of pregnancy.
The main outcome of the study is the number of health care contacts that women have between enrollment in the study and 6 weeks postpartum.
Tipo de estudio
Intervencionista
Inscripción (Estimado)
800
Fase
- No aplica
Contactos y Ubicaciones
Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.
Ubicaciones de estudio
-
-
-
Taabo, Costa de Marfil
- Centre Suisse de Recherches Scientifiques en Cote d'Ivoire
-
Contacto:
- Siaka Koné, PhD
- Número de teléfono: +2250749069627
- Correo electrónico: Siaka.kone@csrs.ci
-
-
Criterios de participación
Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.
Criterio de elegibilidad
Edades elegibles para estudiar
- Niño
- Adulto
- Adulto Mayor
Acepta Voluntarios Saludables
No
Descripción
Inclusion Criteria for Pregnant Women:
- Currently pregnant
- Aged 15 years or older
- Live in the area served by the Taabo Health & Demographic Surveillance System
- Estimated gestational age between 6 completed months of pregnancy and 8 completed months of pregnancy
Inclusion Criteria for Male Partners:
- Aged 15 or older
- Married to or currently the main romantic partner of a woman who is enrolled in the study
Plan de estudios
Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Investigación de servicios de salud
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Sin intervención: Control group
This group will not receive any intervention.
|
|
|
Experimental: Information Video and Planning Session group
This group will receive the study intervention, including an information video and planning session for the pregnant woman and her partner.
|
The study intervention is a video-informed information and planning session for health care during the third trimester, childbirth, and the first six weeks postpartum.
In this intervention, a member of the study team will show information videos to pregnant women and her partner, summarizing key recommendations for health and health care seeking during the third trimester of pregnancy and the first six weeks following childbirth.
After showing the videos, the study team member will guide the pregnant woman and her partner in a short discussion about planning for care-seeking during the third trimester and early postpartum period.
This discussion will include quizzing on the content of the information videos and discussions of care-seeking plans together with the couple.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Number of health care contacts as reported by women during endline survey
Periodo de tiempo: From enrollment to 6 weeks postpartum (measured 6-8 weeks after the end of pregnancy)
|
Number of health care contacts that women have between enrollment in the study and 6 weeks postpartum, including antenatal care visits, childbirth, and postpartum care visits
|
From enrollment to 6 weeks postpartum (measured 6-8 weeks after the end of pregnancy)
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Number of antenatal care visits as reported by women during endline survey
Periodo de tiempo: Between enrollment and the end of pregnancy (measured 6-8 weeks after the end of pregnancy)
|
Number of antenatal care visits
|
Between enrollment and the end of pregnancy (measured 6-8 weeks after the end of pregnancy)
|
|
Facility-based childbirth as reported by women during endline survey
Periodo de tiempo: Measured 6-8 weeks after the end of pregnancy
|
Proportion of women who gave birth in a health facility
|
Measured 6-8 weeks after the end of pregnancy
|
|
Number of postpartum visits as reported by women during endline survey
Periodo de tiempo: From the end of pregnancy to 6 weeks postpartum (measured 6-8 weeks after the end of pregnancy)
|
Number of postpartum care visits between the end of pregnancy and 6 weeks postpartum
|
From the end of pregnancy to 6 weeks postpartum (measured 6-8 weeks after the end of pregnancy)
|
|
Fetal movement counting as reported by women during endline surveys
Periodo de tiempo: Measured 6-8 weeks after the end of pregnancy
|
The proportion of pregnant women who report counting fetal movements at least once during the final month of their pregnancy
|
Measured 6-8 weeks after the end of pregnancy
|
|
Perinatal mortality as reported by women during endline surveys
Periodo de tiempo: Measured 6-8 weeks after end of pregnancy
|
The proportion of women who experience a stillbirth or neonatal death in the first seven days of life (perinatal mortality)
|
Measured 6-8 weeks after end of pregnancy
|
|
Neonatal mortality as reported by women during endline surveys
Periodo de tiempo: Measured 6-8 weeks after end of pregnancy
|
The proportion of women whose child dies in the first 28 days of life
|
Measured 6-8 weeks after end of pregnancy
|
|
Average care-seeking knowledge scores among pregnant women and their partners
Periodo de tiempo: Measured 6-8 weeks after the end of pregnancy
|
Average scores (among pregnant women and their partners) on assessments of knowledge of care-seeking recommendations during the third trimester and the early postpartum period, as measured using five questions during endline surveys with pregnant women and their partners. We create a Care-Seeking Knowledge Scale as follows: Participants receive 1 point if they respond with 3 or more when asked how many postpartum visits women should have during the first 6 weeks after childbirth; 1 point if they correctly name at least 3 danger signs for women during pregnancy; 1 point if they correctly name at least 3 danger signs for women during the first six weeks after childbirth; and 1 point if they correctly name at least 3 danger signs for newborns. Scores range from 0 to 4 with higher scores representing greater knowledge. |
Measured 6-8 weeks after the end of pregnancy
|
Colaboradores e Investigadores
Aquí es donde encontrará personas y organizaciones involucradas en este estudio.
Patrocinador
Fechas de registro del estudio
Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.
Fechas importantes del estudio
Inicio del estudio (Estimado)
1 de septiembre de 2026
Finalización primaria (Estimado)
1 de mayo de 2027
Finalización del estudio (Estimado)
1 de mayo de 2027
Fechas de registro del estudio
Enviado por primera vez
8 de septiembre de 2026
Primero enviado que cumplió con los criterios de control de calidad
8 de septiembre de 2026
Publicado por primera vez (Actual)
14 de septiembre de 2026
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
17 de septiembre de 2026
Última actualización enviada que cumplió con los criterios de control de calidad
14 de septiembre de 2026
Última verificación
1 de septiembre de 2026
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- 2026-19
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
SÍ
Descripción del plan IPD
De-identified data files and analytic code will be posted on public repositories at the time of publication of results.
Marco de tiempo para compartir IPD
We plan to share IPD and supporting information at the time of publication.
Criterios de acceso compartido de IPD
IPD and supporting information will be made available on public repositories.
Tipo de información de apoyo para compartir IPD
- PROTOCOLO DE ESTUDIO
- SAVIA
- CIF
- CÓDIGO_ANALÍTICO
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
No
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
No
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .